SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-021205
Filing Date
2014-04-07
Accepted
2014-04-07 16:48:20
Documents
2
Period of Report
2014-04-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K CURRENT REPORT v374142_8k.htm 8-K 32592
2 EXHIBIT 2.3 v374142_ex2-3.htm EX-2.3 19940
  Complete submission text file 0001144204-14-021205.txt   54315
Mailing Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610
Business Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610 4078490290
CytoCore Inc (Filer) CIK: 0000075439 (see all company filings)

IRS No.: 364296006 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-00935 | Film No.: 14749066
SIC: 3841 Surgical & Medical Instruments & Apparatus